Molecular typing of the actin gene of Trichomonas vaginalis isolates by PCR-restriction fragment length polymorphism

Clinical Microbiology and Infection

Volumn 14, Issue 9, 2008, Pages 844-852

  Crucitti, T ^a   Abdellati, S ^a   Van Dyck, E ^a   Buve A ^a  

^a INSTITUTE OF TROPICAL MEDICINE   (Belgium)

Author keywords

Actin gene; Genotypes; PCR RFLP; T. vaginalis

Indexed keywords

ACTIN; ALPHA ACTIN; E ACTIN; G ACTIN; H ACTIN; I ACTIN; M ACTIN; N ACTIN; P ACTIN; PROTEIN MSEI; PROTEIN RSAI; PROTOZOAL PROTEIN; RESTRICTION ENDONUCLEASE; TYPE II SITE SPECIFIC DEOXYRIBONUCLEASE;

AMINO ACID SUBSTITUTION; ARTICLE; CONGO; CONTROLLED STUDY; FEMALE; GENETIC IDENTIFICATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; MICROBIOLOGICAL EXAMINATION; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SENSITIVITY AND SPECIFICITY; TRICHOMONAS VAGINALIS; VAGINA SECRETION; ZAMBIA;

PROTOZOA; TRICHOMONAS VAGINALIS;

EID: 50149094061     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2008.02034.x     Document Type: Article

References (36)

1. World Health Organization. Global prevalence and incidence of selected curable sexually transmitted infections: Overview and estimates. Geneva, Switzerland: WHO, 2001.
2. Fouts A, Kraus SJ. Trichomonas vaginalis: Reevaluation of its clinical presentation and laboratory diagnosis. J Infect Dis 1980; 141: 137-143.
3. Cates W, Joesoef RJ, Goldman M. A typical pelvic inflammatory disease: can we identify clinical predictors? Am J Obstet Gynecol 1993; 169: 341-346.
4. Cotch MF, Pastorek JG, Nugent RP et al. Trichomonas vaginalis associated with low birth weight and pre-term delivery. Sex Transm Infect 1997; 24: 353-360.
5. Sutton MY, Sternberg M, Nsuami M, Behets F, Nelson AM, St Louis M. Trichomoniasis in pregnant human immunodeficiency virus-infected and human immunodeficiency virus-uninfected Congolese women: Prevalence, risk factors, and association with low birth weight. Am J Obstet Gynecol 1999; 181: 656-662.
6. Cohen MS, Hoffman IF, Royce RA et al. Reduction of concentration of HIV-1 in semen after treatment of urethritis: Implications for prevention of sexual transmission of HIV-1. Lancet 1997; 349: 1868-1875.
7. Laga M, Manoka A, Kivuvu M et al. Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: Results from a cohort study. AIDS 1993; 7: 95-102.
8. McClelland RS, Sangaré L, Hassan WM et al. Infection with Trichomonas vaginalis increases the risk of HIV-1 acquisition. J Infect Dis 2007; 195: 698-702.
9. Sorvillo F, Smith L, Kerndt P, Ash L. Trichomonas vaginalis, HIV, and African-Americans. Emerg Infect Dis 2001; 7: 927-932.
10. Krieger JN, Holmes KK, Spece MR, Rein MF, McCormack WM, Tam MR. Geographic variation among isolates of Trichomonas vaginalis: demonstration of antigenic heterogeneity by using monoclonal antibodies and the indirect immunofluorescence technique. J Infect Dis 1985; 152: 979-984.
11. Proctor EM, Naaykens W, Wong Q, Bowie WR. Isoenzyme patterns of isolates of Trichomonas vaginalis from Vancouver. Sex Transm Dis 1988; 15: 181-185.
12. Singh B. Molecular methods for diagnosis and epidemiological studies of parasitic infections. Int J Parasitol 1997; 27: 1135-1145.
13. Vanacova S, Tachezy J, Kulda J, Flegr J. Characterization of trichomonad species and strains by PCR fingerprinting. J Euk Microbiol 1997; 44: 545-552.
14. Stiles JK, Shar PH, Xue L et al. Molecular typing of Trichomonas vaginalis isolates by HSP70 restriction fragment length polymorphism. Am J Med Hyg 2000; 62: 441-445.
15. Hampl V, Vanacova S, Kulda J, Flegr J. Concordance between genetic relatedness and phenotypic similarities of Trichomonas vaginalis strains. BMC Evol Biol 2001; 1: 11.
16. Fraga J, Rojas L, Sariego I, Sarría CA. Optimization of random amplified polymorphic DNA techniques for use in genetic studies of Trichomonas vaginalis isolates. Infect Genet Evol 2002; 2: 73-75.
17. Lan J, Walboomers JM, Roosendaal R et al. Direct detection and genotyping of Chlamydia trachomatis in cervical scrapes by using polymerase chain reaction and restriction fragment length polymorphism analysis. J Clin Microbiol 1993; 31: 1060-1065.
18. Pillay A, Liu H, Chen CY et al. Molecular subtyping of Treponema pallidum subspecies pallidum. Sex Transm Dis 1998; 25: 408-414.
19. O'Rourke M, Ison CA, Renton AM, Spratt BG. Opa -typing: A high resolution tool for studying the epidemiology of gonorrhoeae. Mol Microbiol 1995; 17: 865-875.
20. Diamond LS. The establishment of various trichomonads of animal and man in axenic cultures. J Parasitol 1957; 43: 488-490.
21. Vandepitte JM, Malele F, Kivuvu DM et al. HIV and other sexually transmitted infections among female sex workers in Kinshasa, Democratic Republic of Congo, in 2002. Sex Transm Dis 2007; 34: 203-208.
22. Kengne P, Veas F, Vidal N, Rey JL, Cuny G. Trichomonas vaginalis: repeated DNA target for highly sensitive and specific polymerase chain reaction diagnosis. Cell Mol Biol 1994; 40: 819-831.
23. Shaio MF, Lin PR, Liu JY. Colorimetric one-tube nested PCR for detection of Trichomonas vaginalis in vaginal discharge. J Clin Microbiol 1997; 35: 132-138.
24. Crucitti T, Van Dyck E, Tehe A et al. Comparison of culture and different PCR assays for detection of Trichomonas vaginalis in self collected vaginal swab specimens. Sex Transm Infect 2003; 79: 393-398.
25. Espinosa N, Hernandez R, Lopez-Griego L, Arroyo R, Lopez-Villasenor I. Differences between coding and non-coding regions in the Trichomonas vaginalis genome: An actin gene as a locus model. Acta Trop 2001; 78: 147-154.
26. Burkhardt HJ. Standardization and quality control of PCR analyses. Clin Chem Lab Med 2000; 38: 87-91.
27. Neumaier M, Braun A, Wagner C. Fundamentals of quality assessment of molecular amplification methods in clinical diagnostics. Clin Chem 1998; 44: 12-26.
28. Bricheux G, Brucherolle G. Molecular cloning of actin genes in Trichomonas vaginalis and phylogeny inferred from actin sequences. FEMS Microbiol Lett 1997; 153: 205-213.
29. Snipes LJ, Gamard PM, Narcisi EM, Beard CB, Lehmann T, Secor WE. Molecular epidemiology of metronidazole resistance in a population of Trichomonas vaginalis clinical isolates. J Clin Microbiol 2000; 38: 3004-3009.
30. Kaul P, Gupta I, Sehgal R, Malla N. Trichomonas vaginalis: Random amplified polymorphic DNA analysis of isolates from symptomatic and asymptomatic women in India. Parasitol Int 2004; 53: 255-262.
31. Rojas L, Fraga J, Sariego I. Genetic variability between Trichomonas vaginalis isolates and correlation with clinical presentation. Infect Genet Evol 2004; 4: 53-58.
32. Arroyo R, Gonzalez-Robles A, Martinez-Palomo A, Alderette JF. Signaling of Trichomonas vaginalis for amoeboid transformation and adhesion synthesis follows cytoadherence. Mol Microbiol 1993; 7: 299-309.
33. Benchimol M. Trichomonads under microscopy. Microsc Microanal 2004; 10: 528-550.
34. Juliano C, Monaco G, Badeira P, Tedde G, Cappuccinelli P. Action of anticytoskeletal compounds on in vitro cytopathic effect phagocytosis, and adhesiveness of Trichomonas vaginalis. Genitourin Med 1987; 63: 256-263.
35. Simões-Barbosa A, Lobo TT, Xavier J, Carvalho SE, Leornadecz E. Trichomonas vaginalis: Intrastrain polymorphisms within the ribosomal intergenic spacer do not correlate with clinical presentation. Exp Parasitol 2005; 110: 108-113.
36. Van Looveren M, Ison CA, Vandamme P et al. Evaluation of the discriminatory power of typing methods for Neisseria gonorrhoeae. J Clin Microbiol 1999; 37: 2183-2188.